We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

202 hedge funds and large institutions have $1.03B invested in PDL BioPharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 202 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $1.09M

Holders
202
Holders Change
+202
Holders Change %
–
% of All Funds
6.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
202
Increased
–
Reduced
–
Closed
–
Calls
$2.13M
Puts
$1.09M
Net Calls
+$1.04M
Net Calls Change
+$1.04M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$8.68M +$8.76M +1,123,806 New
GXMC
27
Global X Management Company
New York
$8.18M +$8.27M +1,060,040 New
JP Morgan Chase
28
JP Morgan Chase
New York
$8.08M +$8.16M +1,046,893 New
Deutsche Bank
29
Deutsche Bank
Germany
$7.86M +$7.95M +1,019,083 New
Goldman Sachs
30
Goldman Sachs
New York
$7.74M +$7.82M +1,002,438 New
BA
31
BlackRock Advisors
Delaware
$7.37M +$7.45M +955,059 New
NI
32
Numeric Investors
Massachusetts
$6.99M +$7.06M +905,938 New
QI
33
QS Investors
New York
$6.88M +$6.95M +891,600 New
TCIM
34
TIAA CREF Investment Management
New York
$6.85M +$6.92M +887,753 New
TC
35
TFS Capital
Pennsylvania
$6.65M +$6.72M +861,769 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$6.32M +$6.38M +818,075 New
QBFM
37
QS Batterymarch Financial Management
New York
$6.18M +$6.25M +800,962 New
GC
38
Guggenheim Capital
Illinois
$6M +$6.06M +777,126 New
Principal Financial Group
39
Principal Financial Group
Iowa
$5.41M +$5.46M +700,426 New
Norges Bank
40
Norges Bank
Norway
$5.36M +$5.41M +693,700 New
Geode Capital Management
41
Geode Capital Management
Massachusetts
$5.19M +$5.24M +672,547 New
Charles Schwab
42
Charles Schwab
California
$4.85M +$4.85M +621,616 New
AI
43
Analytic Investors
California
$4.62M +$4.67M +598,958 New
Wells Fargo
44
Wells Fargo
California
$4.52M +$4.57M +586,172 New
CS
45
Credit Suisse
Switzerland
$4.34M +$4.38M +561,978 New
Wellington Management Group
46
Wellington Management Group
Massachusetts
$4.31M +$4.35M +558,135 New
Capital Fund Management (CFM)
47
Capital Fund Management (CFM)
France
$3.66M +$3.69M +473,700 New
PAM
48
Panagora Asset Management
Massachusetts
$3.61M +$3.65M +467,898 New
DCM
49
Dupont Capital Management
Delaware
$3.52M +$3.55M +455,531 New
MCM
50
McKinley Capital Management
Alaska
$3.5M +$3.53M +452,878 New
1
2
3 4 5

PDLI Hedge Fund Activity: Q2 2013 in Review

202 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q2 2013, worth a combined $1.03B.

Buyers outnumbered sellers: 202 funds opened new PDLI positions and 0 closed out — a net gain of 202 holders — while 0 added to existing stakes and 0 trimmed.

  • 202 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.03B of PDL BioPharma, Inc. stock for Q2 2013.
  • 202 funds opened new PDL BioPharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +202 holders.

Based on aggregated 13F filings for Q2 2013.